MedCram - Medical Lectures Explained CLEARLY | Vilobelimab for Severe COVID-19 and Possibly Other Diseases @Medcram | Uploaded 1 year ago | Updated 13 hours ago
Roger Seheult, MD of MedCram examines vilobelimab in the treatment of severe COVID with possible applications in the treatment of other diseases. See all Dr. Seheult's videos at: medcram.com/?utm_source=Youtube&utm_medium=Video&utm_campaign=Video+Link+Clicks&utm_term=Vilobelimab+for+Severe+COVID-19+and+Possibly+Other+Diseases&utm_content=MVqeeVlmWZ4
(This video was recorded on May 7th, 2023)
Roger Seheult, MD is the co-founder and lead professor at medcram.com/?utm_source=Youtube&utm_medium=Video&utm_campaign=Video+Link+Clicks&utm_term=Vilobelimab+for+Severe+COVID-19+and+Possibly+Other+Diseases&utm_content=MVqeeVlmWZ4
He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.
LINKS / REFERENCES:
Controlling the anaphylatoxin C5a in diseases requires a specifically targeted inhibition (Clinical Immunology) | sciencedirect.com/science/article/abs/pii/S1521661617301729?via%3Dihub
The anti-C5a antibody vilobelimab efficiently inhibits C5a in patients with severe COVID-19 (Clinical and translational science) | pubmed.ncbi.nlm.nih.gov/35029045
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial (Lancet Respir Med) | ncbi.nlm.nih.gov/pmc/articles/PMC9451499/pdf/main.pdf
Treatment With Anti-C5a Antibody Improves the Outcome of H7N9 Virus Infection in African Green Monkeys (Clinical infectious diseases) | ncbi.nlm.nih.gov/pmc/articles/PMC7112341
FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR GOHIBIC (FDA) | fda.gov/media/166824/download
COVID-19 Ventilator Course: Learn or Review Mechanical Ventilation (MedCram) | medcram.com/courses/COVID19-ventilator-mechanical-ventilation?utm_source=Youtube&utm_medium=Video&utm_campaign=Video+Link+Clicks&utm_term=Vilobelimab+for+Severe+COVID-19+and+Possibly+Other+Diseases&utm_content=MVqeeVlmWZ4
All coronavirus updates are at MedCram.com (including more discussion on delta variant covid, COVID Delta, COVID children, natural immunity COVID 19, and more).
MedCram Update 46: youtu.be/EFRwnhfWXxo
MedCram Update 47: youtu.be/H1LHgyfPPQ8
MedCram Update 132: youtu.be/9OZZ6_M4OB0
SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:
youtube.com/user/MEDCRAMvideos?sub_confirmation=1
Get notified of new videos by hitting the bell icon
MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:
MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested.
MEDIA CONTACT:
Media Contact: customers@medcram.com
Media contact info: medcram.com/pages/media-contact?utm_source=Youtube&utm_medium=Video&utm_campaign=Video+Link+Clicks&utm_term=Vilobelimab+for+Severe+COVID-19+and+Possibly+Other+Diseases&utm_content=MVqeeVlmWZ4
Video Produced by Kyle Allred
FOLLOW US ON SOCIAL MEDIA:
facebook.com/MedCram
twitter.com/MedCramVideos
instagram.com/medcram
DISCLAIMER:
MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.
#COVID19 #Omicron #Coronavirus
Roger Seheult, MD of MedCram examines vilobelimab in the treatment of severe COVID with possible applications in the treatment of other diseases. See all Dr. Seheult's videos at: medcram.com/?utm_source=Youtube&utm_medium=Video&utm_campaign=Video+Link+Clicks&utm_term=Vilobelimab+for+Severe+COVID-19+and+Possibly+Other+Diseases&utm_content=MVqeeVlmWZ4
(This video was recorded on May 7th, 2023)
Roger Seheult, MD is the co-founder and lead professor at medcram.com/?utm_source=Youtube&utm_medium=Video&utm_campaign=Video+Link+Clicks&utm_term=Vilobelimab+for+Severe+COVID-19+and+Possibly+Other+Diseases&utm_content=MVqeeVlmWZ4
He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.
LINKS / REFERENCES:
Controlling the anaphylatoxin C5a in diseases requires a specifically targeted inhibition (Clinical Immunology) | sciencedirect.com/science/article/abs/pii/S1521661617301729?via%3Dihub
The anti-C5a antibody vilobelimab efficiently inhibits C5a in patients with severe COVID-19 (Clinical and translational science) | pubmed.ncbi.nlm.nih.gov/35029045
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial (Lancet Respir Med) | ncbi.nlm.nih.gov/pmc/articles/PMC9451499/pdf/main.pdf
Treatment With Anti-C5a Antibody Improves the Outcome of H7N9 Virus Infection in African Green Monkeys (Clinical infectious diseases) | ncbi.nlm.nih.gov/pmc/articles/PMC7112341
FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR GOHIBIC (FDA) | fda.gov/media/166824/download
COVID-19 Ventilator Course: Learn or Review Mechanical Ventilation (MedCram) | medcram.com/courses/COVID19-ventilator-mechanical-ventilation?utm_source=Youtube&utm_medium=Video&utm_campaign=Video+Link+Clicks&utm_term=Vilobelimab+for+Severe+COVID-19+and+Possibly+Other+Diseases&utm_content=MVqeeVlmWZ4
All coronavirus updates are at MedCram.com (including more discussion on delta variant covid, COVID Delta, COVID children, natural immunity COVID 19, and more).
MedCram Update 46: youtu.be/EFRwnhfWXxo
MedCram Update 47: youtu.be/H1LHgyfPPQ8
MedCram Update 132: youtu.be/9OZZ6_M4OB0
SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:
youtube.com/user/MEDCRAMvideos?sub_confirmation=1
Get notified of new videos by hitting the bell icon
MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:
MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested.
MEDIA CONTACT:
Media Contact: customers@medcram.com
Media contact info: medcram.com/pages/media-contact?utm_source=Youtube&utm_medium=Video&utm_campaign=Video+Link+Clicks&utm_term=Vilobelimab+for+Severe+COVID-19+and+Possibly+Other+Diseases&utm_content=MVqeeVlmWZ4
Video Produced by Kyle Allred
FOLLOW US ON SOCIAL MEDIA:
facebook.com/MedCram
twitter.com/MedCramVideos
instagram.com/medcram
DISCLAIMER:
MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.
#COVID19 #Omicron #Coronavirus
